Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep583 | Endocrine-Related Cancer | ECE2022

Novel peptides and cell lines to expand the tools and models to study the potential of the somatostatin system in NETs

Mangili Federica , Moreno Montilla Maria Trinidad , Salamanca Jimenez Pilar , Garcia Vioque Victor , Encinas Rey Ricardo Blazquez , Alors-Perez Emilia , Mantovani Giovanna , Peverelli Erika , Schrader Jo rg , Ibanez Costa Alejandro , Castano Justo P.

Neuroendocrine tumors (NETs) represent a heterogeneous group of malignancies with increasing incidence worldwide, due in part to enhanced awareness and diagnosis improvements. Surgery is often effective for local disease, whereas disseminated or metastatic disease require pharmacological treatment, which is not always successful. Pancreatic (Pan-NETs) and pulmonary (Lung-NETs) neuroendocrine tumors frequently express somatostatin receptors (SSTs), providing the target for trea...

ea0081rc6.8 | Rapid Communications 6: Endocrine-Related Cancer | ECE2022

Unveiling the role and contribution of CELF4 to the malignant features of PanNETs

Vioque Victor Garcia , Alors-Perez Emilia , Arevalo Sergio Pedraza , Agraz-Doblas Antonio , Blazquez-Encinas Ricardo , Blazquez-Encinas Ricardo , Moreno Montilla Maria Trinidad , Herrera-Martinez Aura D , Yubero Serrano Elena Maria , Ortega Salas Rosa , Serrano Blanch Raquel , Galvez Moreno Maria Angeles , Gahete , Manuel D , Costa Alejandro Ibanez , Luque Raul M , Castano Justo P

Pancreatic neuroendocrine tumors (PanNETs) are heterogeneous neoplasms with a relatively low but increasing incidence, mainly due to the difficulty in diagnosing this disease in its early stages. This notably complicates the treatment of this pathology and leads to a poor prognosis. One of the main reasons for this problem is the lack of adequate diagnostic biomarkers as well as effective therapeutic targets. In this sense, there is still a limited knowledge about alternative ...